These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8210921)

  • 1. Meta-analysis of two double-blind comparative studies with the sustained-release form of etodolac in rheumatoid arthritis.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S25-30. PubMed ID: 8210921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S19-24. PubMed ID: 8210920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy of etodolac SR (Lodine SR) and etodolac (Lodine) in patients with rheumatoid arthritis or osteoarthritis.
    Dreiser RL
    Rheumatol Int; 1993; 13(2 Suppl):S13-8. PubMed ID: 8210919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
    Bacon P
    Rheumatol Int; 1993; 13(2 Suppl):S7-12. PubMed ID: 8210924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis.
    Lonauer G; Tisscher JR; Lim HG; Bijlsma JW
    Curr Med Res Opin; 1993; 13(2):70-7. PubMed ID: 8325044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee.
    Khan FM; Williams PI
    Curr Med Res Opin; 1992; 13(1):1-12. PubMed ID: 1468239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.
    Briancon D
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():63-72. PubMed ID: 2525985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile of etodolac in the elderly population.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):19-22. PubMed ID: 7744124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH; Hsu PN
    Curr Med Res Opin; 2003; 19(4):336-41. PubMed ID: 12841927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis.
    Schattenkirchner M
    Curr Med Res Opin; 1991; 12(8):497-506. PubMed ID: 1837260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety profile of sustained-release etodolac.
    Schattenkirchner M
    Rheumatol Int; 1993; 13(2 Suppl):S31-5. PubMed ID: 8210923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose etodolac in rheumatoid arthritis: a review of early studies.
    Spencer-Green G
    J Rheumatol Suppl; 1997 Feb; 47():3-9; discussion 48-50. PubMed ID: 9035014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
    Veys EM
    Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
    Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
    Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis.
    Neustadt DH
    J Rheumatol Suppl; 1997 Feb; 47():17-22. PubMed ID: 9035016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.